PeraMobile and PeraWatch vs ContaCT
AI Verdict
Choose PeraMobile and PeraWatch if…
Choose PeraMobile and PeraWatch if your primary goal is system-wide patient surveillance and early detection of general patient deterioration across various conditions. This tool excels at providing real-time patient acuity scoring (Rothman Index) to proactively identify at-risk patients for earlier intervention, aiming to improve overall quality and reduce costs.
View PeraMobile and PeraWatch →Choose ContaCT if…
Choose ContaCT by Viz.ai if your focus is on accelerating the detection and streamlining care coordination for specific acute conditions like stroke, pulmonary embolism, or cardiac issues. This AI-powered platform is designed to provide real-time alerts and facilitate rapid communication among specialists, ensuring timely treatment for time-sensitive diagnoses.
View ContaCT →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | PeraMobile and PeraWatch | ContaCT |
|---|---|---|
| Pricing | Contact for pricing | Subscription-based |
| Deployment | Software-only, integrated with EHRs, web-based access, mobile application, on user-provided hardware. | Cloud-based, integrates with existing hospital IT infrastructure (PACS, EHR). |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ContaCTTool B (ContaCT) emphasizes a 'High-fidelity 3D web and mobile image viewer' and 'Secure, HIPAA-compliant group communication messaging,' suggesting a more comprehensive and interactive user experience tailored for specialists needing to collaborate on imaging. While Tool A (PeraMobile/PeraWatch) offers mobile access and dashboards, Tool B's features point to a more specialized and potentially richer interactive experience for its target users in critical care scenarios.
Clinical Value
ContaCTWhile both tools offer significant clinical value and are FDA-cleared, Tool B's (ContaCT) focus on accelerating detection and streamlining workflows for time-sensitive, critical conditions like stroke, PE, and aneurysms directly impacts patient morbidity and mortality in a highly measurable way. Its widespread adoption across over 1,700 hospitals globally for these specific use cases demonstrates a strong, proven clinical impact.
Pricing & Value
TieBoth tools are enterprise-level solutions with non-publicly disclosed pricing, requiring direct contact for quotes. While Tool B mentions a 'subscription-based' and 'tiered' model, which could imply flexibility, neither provides enough detail to definitively assess their pricing transparency or value proposition against the other.
Enterprise Readiness
ContaCTViz.ai's ContaCT explicitly states HIPAA compliance and having a Business Associate Agreement (BAA), and its deployment in over 1,700 hospitals globally demonstrates a proven track record of successful enterprise-level integration with PACS and EHR systems. While PeraHealth's solutions are likely compliant and integrate with EHRs, the explicit statements and extensive global adoption of Tool B provide stronger evidence of its enterprise readiness.
Innovation
ContaCTViz.ai's ContaCT is described as a 'pioneering AI-powered care coordination platform' with 'multiple FDA clearances' for AI-driven detection across a range of critical conditions like stroke, PE, and aneurysms. Features like automated chart summarization and guideline-based recommendations further highlight its advanced application of AI for broader clinical workflow optimization, indicating a higher degree of innovation.
Support & Docs
TieBoth PeraHealth (now part of Spacelabs Healthcare) and Viz.ai operate in the enterprise healthcare software space, implying the necessity of robust customer support and documentation. While Spacelabs Healthcare, as a larger entity, likely has extensive support infrastructure, Viz.ai also emphasizes a strong 'customer success' approach with dedicated implementation and ongoing support. Without specific comparative details on their support offerings or documentation quality, it is difficult to definitively choose a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | PeraMobile and PeraWatch | ContaCT |
|---|---|---|
| Product Name | PeraMobile and PeraWatch | ContaCT |
| Company | PeraHealth (acquired by Spacelabs Healthcare) | Viz.AI |
| Primary Use Case / Focus | Identify at-risk patients sooner for earlier intervention, improve quality, and reduce costs (predictive analytics for patient deterioration). | Accelerates disease detection and streamlines clinical workflows (AI-powered care coordination for stroke, LVO, ICH, HCM, PE, Aneurysm). |
| Key Technology / Algorithm | Rothman Index | AI-powered disease detection |
| Mobile Access | Mobile access for on-the-go clinicians (PeraMobile) | Mobile application for specialists to view images and communicate |
| EHR Integration | Integration with major EHR vendors | Integration with PACS and EHR systems |
Videos
Demos, reviews, and walkthroughs featuring PeraMobile and PeraWatch and ContaCT.